Literature DB >> 33984102

Late-Onset Encephalopathy Associated With SARS-CoV-2 Infection.

Katie Reming1, Keithan Sivakumar2, Negar Moheb2, Ahmad Nizam3, Hussam A Yacoub1,2.   

Abstract

Several typical and atypical neurological manifestations of viral pandemics have been reported. Neurological manifestations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have recently been reported. In this case report, we present a patient with encephalopathy as a late neurologic manifestation of SARS-CoV-2 infection. The patient initially tested positive for the novel coronavirus after presenting with fever, cough, and altered mental status. The symptoms resolved within 5 - 7 days and the patient was discharged home. He subsequently developed worsening encephalopathy in the absence of respiratory symptoms, required hospitalization, and tested positive for SARS-CoV-2. Complete workup was unrevealing otherwise. We advise clinicians to be aware of late neurological manifestations of coronavirus disease 2019 (COVID-19) including encephalopathy. Copyright 2020, Reming et al.

Entities:  

Keywords:  COVID-19; Encephalopathy; SARS-CoV-2; Viral infections

Year:  2020        PMID: 33984102      PMCID: PMC8040457          DOI: 10.14740/jnr614

Source DB:  PubMed          Journal:  J Neurol Res        ISSN: 1923-2845


  6 in total

1.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.

Authors:  Ling Mao; Huijuan Jin; Mengdie Wang; Yu Hu; Shengcai Chen; Quanwei He; Jiang Chang; Candong Hong; Yifan Zhou; David Wang; Xiaoping Miao; Yanan Li; Bo Hu
Journal:  JAMA Neurol       Date:  2020-06-01       Impact factor: 18.302

2.  A first case of meningitis/encephalitis associated with SARS-Coronavirus-2.

Authors:  Takeshi Moriguchi; Norikazu Harii; Junko Goto; Daiki Harada; Hisanori Sugawara; Junichi Takamino; Masateru Ueno; Hiroki Sakata; Kengo Kondo; Natsuhiko Myose; Atsuhito Nakao; Masayuki Takeda; Hirotaka Haro; Osamu Inoue; Katsue Suzuki-Inoue; Kayo Kubokawa; Shinji Ogihara; Tomoyuki Sasaki; Hiroyuki Kinouchi; Hiroyuki Kojin; Masami Ito; Hiroshi Onishi; Tatsuya Shimizu; Yu Sasaki; Nobuyuki Enomoto; Hiroshi Ishihara; Shiomi Furuya; Tomoko Yamamoto; Shinji Shimada
Journal:  Int J Infect Dis       Date:  2020-04-03       Impact factor: 3.623

Review 3.  The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.

Authors:  Yan-Chao Li; Wan-Zhu Bai; Tsutomu Hashikawa
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 2.327

4.  Central nervous system manifestations of COVID-19: A systematic review.

Authors:  Ali A Asadi-Pooya; Leila Simani
Journal:  J Neurol Sci       Date:  2020-04-11       Impact factor: 3.181

Review 5.  Nervous system involvement after infection with COVID-19 and other coronaviruses.

Authors:  Yeshun Wu; Xiaolin Xu; Zijun Chen; Jiahao Duan; Kenji Hashimoto; Ling Yang; Cunming Liu; Chun Yang
Journal:  Brain Behav Immun       Date:  2020-03-30       Impact factor: 7.217

6.  Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019.

Authors:  Rong Yin; Wei Feng; Tonghui Wang; Gang Chen; Tao Wu; Dongrui Chen; Tangfeng Lv; Dawei Xiang
Journal:  J Med Virol       Date:  2020-06-29       Impact factor: 20.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.